| 000 | 01726 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516001448.0 | ||
| 264 | 0 | _c20101025 | |
| 008 | 201010s 0 0 eng d | ||
| 022 | _a1532-1827 | ||
| 024 | 7 |
_a10.1038/sj.bjc.6605856 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYang, T-S | |
| 245 | 0 | 0 |
_aA randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients. _h[electronic resource] |
| 260 |
_bBritish journal of cancer _cSep 2010 |
||
| 300 |
_a954-60 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aArginine _xblood |
| 650 | 0 | 4 | _aAsian People |
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xblood |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrolases _xtherapeutic use |
| 650 | 0 | 4 |
_aLiver Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPolyethylene Glycols _xtherapeutic use |
| 650 | 0 | 4 | _aRetreatment |
| 700 | 1 | _aLu, S-N | |
| 700 | 1 | _aChao, Y | |
| 700 | 1 | _aSheen, I-S | |
| 700 | 1 | _aLin, C-C | |
| 700 | 1 | _aWang, T-E | |
| 700 | 1 | _aChen, S-C | |
| 700 | 1 | _aWang, J-H | |
| 700 | 1 | _aLiao, L-Y | |
| 700 | 1 | _aThomson, J A | |
| 700 | 1 | _aWang-Peng, J | |
| 700 | 1 | _aChen, P-J | |
| 700 | 1 | _aChen, L-T | |
| 773 | 0 |
_tBritish journal of cancer _gvol. 103 _gno. 7 _gp. 954-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bjc.6605856 _zAvailable from publisher's website |
| 999 |
_c20141667 _d20141667 |
||